166 related articles for article (PubMed ID: 25170882)
1. Natural history of malignant bone disease in hepatocellular carcinoma: final results of a multicenter bone metastasis survey.
Santini D; Pantano F; Riccardi F; Di Costanzo GG; Addeo R; Guida FM; Ceruso MS; Barni S; Bertocchi P; Marinelli S; Marchetti P; Russo A; Scartozzi M; Faloppi L; Santoni M; Cascinu S; Maiello E; Silvestris F; Tucci M; Ibrahim T; Masi G; Gnoni A; Comandone A; Fazio N; Conti A; Imarisio I; Pisconti S; Giommoni E; Cinieri S; Catalano V; Palmieri VO; Infante G; Aieta M; Trogu A; Gadaleta CD; Brunetti AE; Lorusso V; Silvestris N
PLoS One; 2014; 9(8):e105268. PubMed ID: 25170882
[TBL] [Abstract][Full Text] [Related]
2. Frequency, Morbidity, and Mortality of Bone Metastases in Advanced Hepatocellular Carcinoma.
Harding JJ; Abu-Zeinah G; Chou JF; Owen DH; Ly M; Lowery MA; Capanu M; Do R; Kemeny NE; O'Reilly EM; Saltz LB; Abou-Alfa GK
J Natl Compr Canc Netw; 2018 Jan; 16(1):50-58. PubMed ID: 29295881
[No Abstract] [Full Text] [Related]
3. Risk factors for skeletal-related events (SREs) and factors affecting SRE-free survival for nonsmall cell lung cancer patients with bone metastases.
Ulas A; Bilici A; Durnali A; Tokluoglu S; Akinci S; Silay K; Oksuzoglu B; Alkis N
Tumour Biol; 2016 Jan; 37(1):1131-40. PubMed ID: 26276360
[TBL] [Abstract][Full Text] [Related]
4. Natural history of malignant bone disease in gastric cancer: final results of a multicenter bone metastasis survey.
Silvestris N; Pantano F; Ibrahim T; Gamucci T; De Vita F; Di Palma T; Pedrazzoli P; Barni S; Bernardo A; Febbraro A; Satolli MA; Bertocchi P; Catalano V; Giommoni E; Comandone A; Maiello E; Riccardi F; Ferrara R; Trogu A; Berardi R; Leo S; Bertolini A; Angelini F; Cinieri S; Russo A; Pisconti S; Brunetti AE; Azzariti A; Santini D
PLoS One; 2013; 8(10):e74402. PubMed ID: 24204569
[TBL] [Abstract][Full Text] [Related]
5. Natural history of malignant bone disease in renal cancer: final results of an Italian bone metastasis survey.
Santini D; Procopio G; Porta C; Ibrahim T; Barni S; Mazzara C; Fontana A; Berruti A; Berardi R; Vincenzi B; Ortega C; Ottaviani D; Carteni G; Lanzetta G; Virzì V; Santoni M; Silvestris N; Satolli MA; Collovà E; Russo A; Badalamenti G; Fedeli SL; Tanca FM; Adamo V; Maiello E; Sabbatini R; Felici A; Cinieri S; Tonini G; Bracarda S
PLoS One; 2013; 8(12):e83026. PubMed ID: 24386138
[TBL] [Abstract][Full Text] [Related]
6. Increased incidence of bone metastases in hepatocellular carcinoma.
Fukutomi M; Yokota M; Chuman H; Harada H; Zaitsu Y; Funakoshi A; Wakasugi H; Iguchi H
Eur J Gastroenterol Hepatol; 2001 Sep; 13(9):1083-8. PubMed ID: 11564960
[TBL] [Abstract][Full Text] [Related]
7. ¹⁸F-FDG PET/CT in hepatocellular carcinoma: detection of bone metastasis and prediction of prognosis.
Seo HJ; Kim GM; Kim JH; Kang WJ; Choi HJ
Nucl Med Commun; 2015 Mar; 36(3):226-33. PubMed ID: 25460306
[TBL] [Abstract][Full Text] [Related]
8. Early detection of bone metastases of hepatocellular carcinoma reduces bone fracture and paralysis.
Hirai T; Shinoda Y; Tateishi R; Asaoka Y; Uchino K; Wake T; Kobayashi H; Ikegami M; Sawada R; Haga N; Koike K; Tanaka S
Jpn J Clin Oncol; 2019 Jun; 49(6):529-536. PubMed ID: 30957835
[TBL] [Abstract][Full Text] [Related]
9. Bone metastases from hepatocellular carcinoma: clinical features and prognostic factors.
Lu Y; Hu JG; Lin XJ; Li XG
Hepatobiliary Pancreat Dis Int; 2017 Oct; 16(5):499-505. PubMed ID: 28992882
[TBL] [Abstract][Full Text] [Related]
10. A rare presentation of osseous metastasis in Hepatocellular Carcinoma (HCC) on bone scintigraphy.
Asghar N; Hassan A
J Pak Med Assoc; 2018 Sep; 68(9):1415. PubMed ID: 30317280
[TBL] [Abstract][Full Text] [Related]
11. The diagnostic and prognostic effectiveness of F-18 sodium fluoride PET-CT in detecting bone metastases for hepatocellular carcinoma patients.
Yen RF; Chen CY; Cheng MF; Wu YW; Shiau YC; Wu K; Hong RL; Yu CJ; Wang KL; Yang RS
Nucl Med Commun; 2010 Jul; 31(7):637-45. PubMed ID: 20389259
[TBL] [Abstract][Full Text] [Related]
12. Positive lymph node metastasis has a marked impact on the long-term survival of patients with hepatocellular carcinoma with extrahepatic metastasis.
Xia F; Wu L; Lau WY; Li G; Huan H; Qian C; Ma K; Bie P
PLoS One; 2014; 9(4):e95889. PubMed ID: 24760012
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular Carcinoma with Bone Metastases: Incidence, Prognostic Significance, and Management-Single-Center Experience.
Bhatia R; Ravulapati S; Befeler A; Dombrowski J; Gadani S; Poddar N
J Gastrointest Cancer; 2017 Dec; 48(4):321-325. PubMed ID: 28891006
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and prognostic nomograms for bone metastasis in hepatocellular carcinoma.
Hu C; Yang J; Huang Z; Liu C; Lin Y; Tong Y; Fan Z; Chen B; Wang C; Zhao CL
BMC Cancer; 2020 Jun; 20(1):494. PubMed ID: 32487048
[TBL] [Abstract][Full Text] [Related]
15. Improved oncologic outcomes by ablative radiotherapy in patients with bone metastasis from hepatocellular carcinoma.
Kim TH; Park S; Rim CH; Choi C; Seong J
J Cancer Res Clin Oncol; 2021 Sep; 147(9):2693-2700. PubMed ID: 33582874
[TBL] [Abstract][Full Text] [Related]
16. Importance of achieving complete necrosis during the first treatment for hepatocellular carcinoma to prevent bone metastasis: a prospective study.
Iwata M; Kaneko S; Terasaki S; Matsushita E; Urabe T; Kobayashi K; Matsui O
J Gastroenterol Hepatol; 2001 Jan; 16(1):46-51. PubMed ID: 11206316
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma with extrahepatic metastasis: clinical features and prognostic factors.
Uchino K; Tateishi R; Shiina S; Kanda M; Masuzaki R; Kondo Y; Goto T; Omata M; Yoshida H; Koike K
Cancer; 2011 Oct; 117(19):4475-83. PubMed ID: 21437884
[TBL] [Abstract][Full Text] [Related]
18. Bone metastasis and skeletal-related events in patients with solid cancer: A Korean nationwide health insurance database study.
Hong S; Youk T; Lee SJ; Kim KM; Vajdic CM
PLoS One; 2020; 15(7):e0234927. PubMed ID: 32678818
[TBL] [Abstract][Full Text] [Related]
19. Is female sex a significant favorable prognostic factor in hepatocellular carcinoma?
Farinati F; Sergio A; Giacomin A; Di Nolfo MA; Del Poggio P; Benvegnù L; Rapaccini G; Zoli M; Borzio F; Giannini EG; Caturelli E; Trevisani F;
Eur J Gastroenterol Hepatol; 2009 Oct; 21(10):1212-8. PubMed ID: 19465859
[TBL] [Abstract][Full Text] [Related]
20. Factors Associated With Increased Risk of De Novo or Recurrent Hepatocellular Carcinoma in Patients With Cirrhosis Treated With Direct-Acting Antivirals for HCV Infection.
Degasperi E; D'Ambrosio R; Iavarone M; Sangiovanni A; Aghemo A; Soffredini R; Borghi M; Lunghi G; Colombo M; Lampertico P
Clin Gastroenterol Hepatol; 2019 May; 17(6):1183-1191.e7. PubMed ID: 30613002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
